Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism NF-κB inhibitors(Nuclear factor NF-kappa-B complex inhibitors), p38 MAPK inhibitors(P38 mitogen-activated protein kinase inhibitors), Apoptosis inhibitors |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colitis, Ulcerative | Preclinical | CN | 21 May 2024 | |
Diabetes Mellitus | Preclinical | CN | 28 Feb 2024 |